Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal.

Sukel, Myrthe P P

Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal. [electronic resource] - Pharmacoepidemiology and drug safety Jan 2008 - 9-19 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1053-8569

10.1002/pds.1508 doi


Anti-Inflammatory Agents, Non-Steroidal--adverse effects
Arthritis, Rheumatoid--drug therapy
Cardiovascular Diseases--prevention & control
Cohort Studies
Cyclooxygenase 2 Inhibitors--administration & dosage
Databases, Factual
Drug Prescriptions--statistics & numerical data
Drug Therapy, Combination
Drug Utilization Review
Drug and Narcotic Control
Female
Gastrointestinal Diseases--chemically induced
Humans
Lactones--administration & dosage
Male
Middle Aged
Practice Patterns, Physicians'--statistics & numerical data
Proton Pump Inhibitors
Sulfones--administration & dosage